> If you could have some before/after numbers, that would be cool. Does any test infrastructure (or benchmarks) exist which you would trust for corresponding comparisons of software run time characteristics? > If you collect your patches into one series, you could at least do measurements > before/after the series. How do you think about to check possible improvements by each presented patch according to affected SmPL scripts individually? > Or if you could make some other sort of claim around "this shouldn't > affect this-or-that because so-and-so". I try to avoid such claims. But I provided specific information in my patch descriptions. Do you find any details reasonable there? > Do you mean whether I would like to clarify the risks I see, or do you > mean whether I would like you to clarify which you see? Both. - The discussion will depend also on your change acceptance and desire to extend development in the shown software design directions. > I've tried to clarify the one I see -- based on passively observing cocci-related > patches floating around this list. Thanks for your interest. > If you see other potential risks, feel free to mention them. I would prefer a more optimistic view while my software development experiences can influence this considerably. > You seem to know lots more than I do about these things. This can be. - But I hope that you can get further inspirations and ideas if you would find any of the published development activities interesting enough. Regards, Markus
